1. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease;Brogden;Allergol. E.T. Immunopath.,1992
2. The characterisation of the major metabolite of salmeterol in the dog;Bowers;J. Pharm. Biomed. Anal.,1998
3. The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A;Manchee;Drug Metab. Dispos.,1996
4. Disposition of salmeterol xinafoate in laboratory animals and humans;Manchee;Drug Metab. Dispos.,1993